World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Invitation to the presentation of ASSA ABLOY’s Q1 report on 28 April at 9:00 a.m. (CEST)

Cision PR Newswire by Cision PR Newswire
April 2, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

STOCKHOLM, April 2, 2026 /PRNewswire/ — ASSA ABLOY will release its Q1 2026 report on 28 April 2026 at 8:00 a.m. (CEST). A conference call and webcast will be held following the release of the results, starting at 9:00 a.m. (CEST) and ending at 10:00 a.m. (CEST). The presentation will be hosted by Nico Delvaux, President & CEO, and Erik Pieder, CFO, followed by a Q&A session.

Slides used during the presentation will be available on the ASSA ABLOY website shortly after the release of the report.

Enter the conference call and download presentation materials at: assaabloy.com/investors

The details for participation by telephone are as follows:

  • Participants in Sweden should call +46 8 5051 00 31
  • Participants in the UK/Europe should call +44 207 107 06 13
  • Participants in the United States should call +1 631 570 56 13
  • Other international numbers available HERE

For more information, please contact: 
Isabelle Ewerlöf Travers, Investor Relations Officer
isabelle.ewerlof@assaabloy.com
Tel: +46 8 506 485 74

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/assa-abloy/r/invitation-to-the-presentation-of-assa-abloy-s-q1-report-on-28-april-at-9-00-a-m—cest-,c4329433

The following files are available for download:

https://mb.cision.com/Public/7333/4329433/b7d5ef7f88bde3db.pdf

ASSA ABLOY Q1 2026 invitation

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-assa-abloys-q1-report-on-28-april-at-900-am-cest-302732454.html

Cision PR Newswire

Cision PR Newswire

Related Posts

The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses

July 15, 2026

Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

July 15, 2026

LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026

July 15, 2026

A Hitachi Group site selected as “Global Lighthouse Factory” by the World Economic Forum, marking the Group’s second designation

July 15, 2026

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

July 15, 2026

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

July 14, 2026

Popular News

  • Corgi Insurance Launches Golden, a Dedicated Sports and Entertainment Insurance Vertical Built for the $600 Billion Sports Industry

    0 shares
    Share 0 Tweet 0
  • LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026

    0 shares
    Share 0 Tweet 0
  • Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

    0 shares
    Share 0 Tweet 0
  • The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses

    0 shares
    Share 0 Tweet 0
  • Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler